| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-3083.2012.02701.X |
| P953 | full work available online at | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-3083.2012.02701.x |
| https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-3083.2012.02701.x | ||
| P698 | PubMed publication ID | 22469080 |
| P5875 | ResearchGate publication ID | 223981710 |
| P2093 | author name string | B. Magnusson | |
| M. Jontell | |||
| E. Telemo | |||
| J. Öhman | |||
| B. Hasséus | |||
| P2860 | cites work | Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules | Q22011207 |
| Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Langerin/CD207 Sheds Light on Formation of Birbeck Granules and Their Possible Function in Langerhans Cells | Q28183293 | ||
| Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
| The three Es of cancer immunoediting | Q28251475 | ||
| Cancer despite immunosurveillance: immunoselection and immunosubversion | Q28263865 | ||
| Immune response against dying tumor cells | Q28271233 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Natural Innate and Adaptive Immunity to Cancer | Q29620313 | ||
| Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management | Q33357133 | ||
| Prognostic relevance of cell proliferation in head and neck tumors | Q35866615 | ||
| Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons | Q36375059 | ||
| Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells | Q36375909 | ||
| Management of oral epithelial dysplasia: a review. | Q36719978 | ||
| Molecular genetics of premalignant oral lesions | Q36738070 | ||
| Phagocytosis and antigen presentation in dendritic cells | Q36938623 | ||
| Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas | Q37160638 | ||
| CD4 and CD8: an inside-out coreceptor model for innate immune cells. | Q37463558 | ||
| Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses | Q37690379 | ||
| Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors | Q37735454 | ||
| Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma | Q38283313 | ||
| Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo. | Q39724582 | ||
| Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination | Q40105174 | ||
| Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes | Q40143132 | ||
| Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma | Q42441474 | ||
| Expression modes and clinical manifestations of latent membrane protein 1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma. | Q43494431 | ||
| Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration | Q44099824 | ||
| Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas | Q44281294 | ||
| Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4. | Q51752446 | ||
| Lymph node metastases in oral carcinoma. A correlation of histopathology with survival. | Q52917963 | ||
| Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells | Q53361099 | ||
| Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer | Q57571531 | ||
| Differential infiltration of CD8+and NK cells in lip and oral cavity squamous cell carcinoma | Q59387661 | ||
| Epithelial dendritic cells in pathological human oral tissues | Q69083785 | ||
| Oral leukoplakia and malignant transformation. A follow-up study of 257 patients | Q70788858 | ||
| Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity | Q71563753 | ||
| Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity | Q71803456 | ||
| S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival | Q72379747 | ||
| Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells | Q73263424 | ||
| Langerhans Cells and T Cells in Oral Graft versus Host Disease and Oral Lichen Planus | Q77129017 | ||
| Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. an immunohistochemical study | Q78401277 | ||
| Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor | Q79722087 | ||
| Langerin-expressing and CD83-expressing cells in oral lichen planus lesions | Q80359873 | ||
| Phenotypic characterization and distribution of dendritic cells in parotid gland tumors | Q81314064 | ||
| Long-term treatment outcome of oral premalignant lesions | Q81550176 | ||
| Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck | Q81739802 | ||
| Evidence for immunosurveillance in intestinal premalignant lesions | Q84297091 | ||
| Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer | Q84889571 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 39-48 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Scandinavian Journal of Immunology | Q15762682 |
| P1476 | title | Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance | |
| Langerhans Cells and T Cells Sense Cell Dysplasia in Oral Leukoplakias and Oral Squamous Cell Carcinomas – Evidence for Immunosurveillance | |||
| P478 | volume | 76 |
| Q47195265 | A Believer's Overview of Cancer Immunosurveillance and Immunotherapy |
| Q46448653 | CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma. |
| Q33688026 | Histopathological characterization of the oral lichenoid disease subtypes and the relation with the clinical data |
| Q38741445 | Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis. |
| Q42142277 | Langerhans Cell Expression in Oral Submucous Fibrosis: An Immunohistochemical Analysis |
| Q43169264 | Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy |
| Q37274307 | Premalignant Oral Lesion Cells Elicit Increased Cytokine Production and Activation of T-cells |
| Q39107022 | Redirecting the focus of cancer immunotherapy to premalignant conditions |
| Q49566629 | The dawn of vaccines for cancer prevention |
| Q34718331 | Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study |
Search more.